// App-Quantinova.ai

344 2014 HTN : Endothelin-1 Overexpression Exaggerates Diabetes-induced Endothelial Dysfunction

Researchers

Presenter

  • Muhammad Oneeb Rehman Mian

Principal Investigators

  • Tlili Barhoumi

  • Sofiane Ouerd

  • Jordan Gornitsky

  • Pierre Paradis

  • Ernesto L Schiffrin

Medical Centers

  • Lady Davis Inst. for Med. Rsch., Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Vasodilation dysfunction

  • Type 1 diabetes mellitus

  • Diabetes

Biomarkers

  • Endothelin-1

Drug/Treatment

  • Nitroprusside sodium

  • Meclofenamic acid

  • Streptozotocin

  • Acetylcholine

  • endothelin-1

  • Nitric oxide

  • DE-074

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim